DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA. Mediterr J Hematol Infect Dis [Internet]. 2019 Feb. 26 [cited 2026 Jul. 21];11(1):e2019016. Available from: https://www.mjhid.org/mjhid/article/view/2019.016